Range
0.78 - 0.82
Vol / Avg.
2.2M/1.3M
Div / Yield
-
52 Wk
0.66 - 2.22
Mkt Cap
161.5M
Payout Ratio
-
Open
0.81
P/E
-
EPS
-0.03
Shares
204.3M
Outstanding
204.3M
Total Float
196.5M
Benzinga - Mar 29, 2021, 6:31AM
Benzinga - Aug 10, 2020, 4:41PM
load more
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.030-0.030 0.0000
REV20.000K33.333K13.333K
Q4 2020Est.ActualSurprise
EPS-0.030-0.030 0.0000
REV1.020M62.500K-957.500K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
MTNBMatinas BioPharma Hldgs-2.42%161.5M

Matinas BioPharma Hldgs Frequently Asked Questions

Q

How do I buy Matinas BioPharma Hldgs (MTNB) stock?

A

You can purchase shares of Matinas BioPharma Hldgs (AMEX: MTNB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Matinas BioPharma Hldgs's (MTNB) competitors?

A

There are no as such competitors for Matinas BioPharma Hldgs.

Q

What is the target price for Matinas BioPharma Hldgs (MTNB) stock?

A

The latest price target for Matinas BioPharma Hldgs (AMEX: MTNB) was reported by Aegis Capital on August 13, 2020. The analyst firm set a price target for 3.50 expecting MTNB to rise to within 12 months (a possible 342.81% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Matinas BioPharma Hldgs (MTNB)?

A

The stock price for Matinas BioPharma Hldgs (AMEX: MTNB) is $0.7904 last updated Tue Jun 22 2021 19:59:41 GMT+0000 (Coordinated Universal Time).

Q

Does Matinas BioPharma Hldgs (MTNB) pay a dividend?

A

There are no upcoming dividends for Matinas BioPharma Hldgs.

Q

When is Matinas BioPharma Hldgs (AMEX:MTNB) reporting earnings?

A
Matinas BioPharma Hldgs’s Q2 earnings are confirmed for after-market on August 9, 2021.
Q

Is Matinas BioPharma Hldgs (MTNB) going to split?

A

There is no upcoming split for Matinas BioPharma Hldgs.

Q

What sector and industry does Matinas BioPharma Hldgs (MTNB) operate in?

A

Matinas BioPharma Hldgs is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the AMEX.